U.S. Markets close in 1 hr 59 mins
  • S&P 500

    3,635.02
    +57.43 (+1.61%)
     
  • Dow 30

    30,026.34
    +435.07 (+1.47%)
     
  • Nasdaq

    12,047.04
    +166.40 (+1.40%)
     
  • Russell 2000

    1,855.47
    +37.18 (+2.04%)
     
  • Crude Oil

    44.94
    +1.88 (+4.37%)
     
  • Gold

    1,804.50
    -33.30 (-1.81%)
     
  • Silver

    23.31
    -0.33 (-1.39%)
     
  • EUR/USD

    1.1885
    +0.0039 (+0.3328%)
     
  • 10-Yr Bond

    0.8720
    +0.0150 (+1.75%)
     
  • Vix

    21.94
    -0.72 (-3.18%)
     
  • GBP/USD

    1.3361
    +0.0039 (+0.2913%)
     
  • USD/JPY

    104.5450
    +0.0570 (+0.0546%)
     
  • BTC-USD

    19,166.48
    +714.52 (+3.87%)
     
  • CMC Crypto 200

    380.08
    +10.33 (+2.79%)
     
  • FTSE 100

    6,432.17
    +98.33 (+1.55%)
     
  • Nikkei 225

    26,165.59
    +638.22 (+2.50%)
     

Prothena Corp PLC (PRTA) Files 10-K for the Fiscal Year Ended on December 31, 2018

GuruFocus.com

- By insider

Prothena Corp PLC (PRTA) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Prothena Corp PLC is a biotechnology company. It discovers and develops novel antibodies for the potential treatment of a broad range of diseases that involve protein misfolding or cell adhesion. Prothena Corp PLC has a market cap of $572.040 million; its shares were traded at around $14.35 with and P/S ratio of 574.00.


For the last quarter Prothena Corp PLC reported a revenue of $0.19 million, compared with the revenue of $0.23 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $0.96 million, a decrease of 96.5% from the previous year. For the last five years Prothena Corp PLC had an average revenue decline of 1.5% a year.

The reported loss per diluted share was $3.93 for the year, compared with the loss per share of $0.29 in the previous year. The Prothena Corp PLC had an operating margin of -14943.46%, compared with the operating margin of -564.17% a year before. The 10-year historical median operating margin of Prothena Corp PLC is -3266.12%. The profitability rank of the company is 4 (out of 10).

At the end of the fiscal year, Prothena Corp PLC has the cash and cash equivalents of $427.7 million, compared with $417.6 million in the previous year. The company had no long term debt, compared with $51.5 million in the previous year. Prothena Corp PLC has a financial strength rank of 5 (out of 10).

At the current stock price of $14.35, Prothena Corp PLC is traded at 79.8% premium to its historical median P/S valuation band of $7.98. The P/S ratio of the stock is 574.00, while the historical median P/S ratio is 319.37. The stock lost 59.69% during the past 12 months.

For the complete 20-year historical financial data of PRTA, click here.

This article first appeared on GuruFocus.